Emtherapro provides a next-generation precision medicine enablement solution for neurodegenerative diseases, combining precision proteomics with advanced ML/AI and systems biology analytics to generate insights that support biomarker identification, diagnostics, and therapy development.
Developer of precision medicine technologies designed to address unmet needs in immune-mediated and inflammatory diseases. The company offers features such as a proprietary data analytics engine that harmonizes extensive patient molecular profiles, identifies novel therapeutic targets, and develops diagnostics, enabling researchers and healthcare providers to create targeted therapies based on individual genetics, ultimately improving treatment outcomes for patients suffering from chronic conditions.
Telememory, LLC is a telehealth startup based in Kansas City that uses AI-based digital reminiscence technology to connect families with memories and track emotional responses to support seniors' happiness and health.